VMP using weekly and subcutaneous bortezomib is well tolerated and efficacious for newly diagnosed and relapsed myeloma patients

被引:0
|
作者
O'Sullivan, J. M. [1 ]
Kumar, S. [1 ]
Yeomans, C. [1 ]
Milner, G. [1 ]
Schey, S. [1 ]
Kazmi, M. [1 ]
Streetly, M. J. [1 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, Dept Haematol, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
154
引用
收藏
页码:64 / 65
页数:2
相关论文
共 50 条
  • [31] Daratumumab combinations for patients with newly diagnosed and relapsed multiple myeloma
    Popat, Rakesh
    Chavda, Selina
    LANCET HAEMATOLOGY, 2023, 10 (10): : E788 - E789
  • [32] A Phase III Study of VMPT Versus VMP in Newly Diagnosed Elderly Myeloma Patients
    Palumbo, A.
    Cangialosi, C.
    Gottardi, D.
    Elice, F.
    Bringhen, S.
    Rossi, D.
    Magarotto, V.
    Baldini, L.
    Morabito, F.
    Musolino, C.
    Falcone, A.
    De Rosa, L.
    Ceccolini, M.
    Ciambelli, F.
    Zambello, R.
    Ferrara, F.
    Musto, P.
    Omede, P.
    Di Raimondo, F.
    Boccadoro, M.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S19 - S19
  • [33] Comparative Efficacy and Safety of Daratumumab in Combination with Bortezomib, Melphalan, and Prednisone (D-VMP) in Alcyone Versus Bortezomib, Melphalan, and Prednisone (VMP) in Vista in Newly Diagnosed Multiple Myeloma (NDMM) Patients Using Propensity Score Matching (PSM)
    Cavo, Michele
    Dimopoulos, Meletios A.
    San-Miguel, Jesus F.
    Mateos, Maria-Victoria
    Jakubowiak, Andrzej
    Deraedt, William
    Lam, Annette
    Kampfenkel, Tobias
    Qi, Ming
    He, Jianming
    BLOOD, 2018, 132
  • [34] Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
    Sanchez, Larysa
    Richter, Joshua
    Cho, Hearn Jay
    Jagannath, Sundar
    Madduri, Deepu
    Parekh, Samir
    Richard, Shambavi
    Tam, Lowena
    Verina, Daniel
    Chari, Ajai
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [35] Bortezomib (Velcade), Thalidomide, Dexamethasone and Panobinostat (VTD-P) Is a Safe, Well Tolerated and Efficacious Regimen for Patients with Relapsed Multiple Myeloma: Preliminary Results of the Muk-Six Trial
    Popat, Rakesh
    Brown, Sarah R.
    Flanagan, Louise M.
    Hall, Andrew
    Kishore, Bhuvan
    Streetly, Matthew
    Oakervee, Heather E.
    Hallam, Simon L.
    Smith, Matthew
    Yong, Kwee L.
    Cook, Gordon
    Cavenagh, James D.
    BLOOD, 2015, 126 (23)
  • [36] The Choice Of Regimens Based On Bortezomib For Patients With Newly Diagnosed Multiple Myeloma
    Yang, Li
    He, Jingsong
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Li, Li
    Zhang, Jie
    Huang, Weijia
    Zhao, Yi
    Huang, He
    Zhang, Xuejin
    Fu, Jiaping
    Cai, Zhen
    BLOOD, 2013, 122 (21)
  • [37] Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients
    Mersin, Sinan
    Geduk, Ayfer
    Mehtap, Ozgur
    Tarkun, Pinar
    Unal, Serkan
    Polat, Merve Gokcen
    Aygun, Kemal
    Yenihayat, Emel Merve
    Albayrak, Hayrunnisa
    Hacihanifioglu, Abdullah
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (03) : 211 - 217
  • [38] Combination Therapy Based on Bortezomib for Newly Diagnosed Multiple Myeloma Patients
    He, Jingsong
    Yang, Li
    Jin, Dian
    Lin, Xuanru
    Yang, Qianqian
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Zhang, Jie
    Lin, Maofang
    Huang, He
    Cai, Zhen
    BLOOD, 2012, 120 (21)
  • [39] COMBINATION THERAPY BASED ON BORTEZOMIB FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Cai, C.
    He, J.
    Yang, Y.
    Han, H.
    Zheng, G.
    Zheng, W.
    Wei, W.
    Wu, W.
    Ye, Y.
    Shi, S.
    Xie, X.
    Li, L.
    Zhang, Z.
    Huang, H.
    Huang, H.
    Zhen, Z.
    HAEMATOLOGICA, 2012, 97 : 611 - 611
  • [40] The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma
    He, Jingsong
    Yang, Li
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Li, Li
    Zhang, Jie
    Huang, Weijia
    Zhao, Yi
    Huang, He
    Zhang, Xuejin
    Fu, Jiaping
    Cai, Zhen
    PLOS ONE, 2014, 9 (06):